ATP-sensitive inward rectifier potassium channel 6.1 (Kir6.1)

ATP-sensitive inward rectifier potassium channel 6.1 (Kir6.1), encoded by the KCNJ8 gene, is a critical pore-forming subunit of the ATP-sensitive potassium (KATP) channel complex (UniProt: P48549). These channels function as metabolic sensors that couple the intracellular energetic state, specifically the ATP/ADP ratio, to membrane excitability; they close when ATP levels are high and open during metabolic stress or hypoxia (PubMed: 25339645). Kir6.1 is predominantly expressed in vascular smooth muscle cells and the heart, where it plays a vital role in regulating vascular resistance and protecting tissues during ischemic events (PubMed: 21164015). Gain-of-function mutations in KCNJ8 are a primary cause of Cantu syndrome, a complex disorder characterized by hypertrichosis, cardiomegaly, and vascular abnormalities (PubMed: 22541557). Conversely, certain variants are associated with J-wave syndromes, including Brugada syndrome and early repolarization syndrome, which increase the risk of sudden cardiac death (PubMed: 20301603). From a pharmacological perspective, Kir6.1-containing channels are targeted by potassium channel openers like pinacidil to promote vasodilation and are inhibited by sulfonylureas such as glibenclamide, which are traditionally used in metabolic and cardiovascular research (PubMed: 10484368).

Other names

KCNJ8Potassium inwardly rectifying channel subfamily J member 8uKATP-1BIRPotassium channel, inwardly rectifying subfamily J member 8

Potassium channel openers (KCOs) increase the open-state probability of the Kir6.1-containing KATP channel complex to induce membrane hyperpolarization and smooth muscle relaxation, while sulfonylureas inhibit the channel by binding to associated sulfonylurea receptors (SUR) to prevent potassium efflux.